Mark U. Rarick
Impact in
- Hematology top 1%
- Erythropoietin and Anemia Treatment
- Iron Metabolism and Disorders
- Oncology top 2%
- Viral-associated cancers and disorders
Papers in
- Co-authors
- Alexandra M. Levine (11 shared papers)Parkash S. Gill (9 shared papers)Marjorie Bernstein-Singer (9 shared papers)Carmen L. Loureiro (5 shared papers)Mark Krailo (4 shared papers)Byron M. Espina (11 shared papers)Parkash S. Gill (3 shared papers)Bisher Akil (5 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Blood (6 papers)Annals of Oncology (5 papers)Cancer (4 papers)AIDS (3 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Mark U. Rarick
48 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 113
- Hematology 715
- Oncology 1.2k
- Pathology and Forensic Medicine 563
- Genetics 304
- Virology 120
Countries citing papers authored by Mark U. Rarick
This map shows the geographic impact of Mark U. Rarick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark U. Rarick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark U. Rarick more than expected).
Fields of papers citing papers by Mark U. Rarick
This network shows the impact of papers produced by Mark U. Rarick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark U. Rarick. The network helps show where Mark U. Rarick may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark U. Rarick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 364 | |
| 2 | 2002 | 320 | |
| 3 | 2007 | 247 | |
| 4 | 1991 | 168 | |
| 5 | 1987 | 159 | |
| 6 | 2014 | 153 | |
| 7 | 1989 | 149 | |
| 8 | 2014 | 146 | |
| 9 | 1996 | 132 | |
| 10 | 2007 | 116 | |
| 11 | 1989 | 108 | |
| 12 | 1990 | 79 | |
| 13 | 1988 | 74 | |
| 14 | 2001 | 73 | |
| 15 | 1990 | 50 | |
| 16 | Bone marrow examination for the diagnosis of mycobacterial and fungal infections in the acquired immunodeficiency syndrome. | 1991 | 47 |
| 17 | 1992 | 43 | |
| 18 | 2007 | 43 | |
| 19 | 2011 | 37 | |
| 20 | 1992 | 35 |
About Mark U. Rarick
Mark U. Rarick is a scholar working on Oncology, Genetics, Pathology and Forensic Medicine, Hematology and Neurology, having authored 48 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Erythropoietin and Anemia Treatment (5 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Blood groups and transfusion (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Platelet Disorders and Treatments (3 papers). The work is most often cited by research in Hematology (715 citations), Oncology (1.2k citations), Pathology and Forensic Medicine (563 citations), Genetics (304 citations) and Virology (120 citations). Mark U. Rarick has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Alexandra M. Levine, Parkash S. Gill, Marjorie Bernstein-Singer, Carmen L. Loureiro, Mark Krailo, Byron M. Espina, Parkash S. Gill, Bisher Akil, David Cella and Matthew J. Goode. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, Cancer and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.